Insider trades
Column Group IV-A, 10% Owner of Eikon Therapeutics EIKN, has filed 13 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $38.1M. The latest trade was on 02/06.
Column Group IV-A
10% Owner
- Company
- Eikon Therapeutics EIKN
- First filing
- 23/01/17
- Trades
- 45 trades
- Buys / sales
- 13 / 0
- 12-month net buying
- $38.1M
- Last trade
- 02/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 02/06 | 02/09 | 2,117,760 sh3 trades | $18.00avg. | $38,119,680 | No record | |
| Open-market buy | 23/11/15–23/11/16 | 23/11/17 | 22,631 sh2 trades | $0.69avg. | $15,542.41 | +2.4% | |
| Open-market buy | 23/01/30–23/01/31 | 23/02/01 | 184,272 sh2 trades | $5.00avg. | $921,360 | +24.8% | |
| Open-market buy | 23/01/23 | 23/01/25 | 9,900 sh | $5.00 | $49,500 | +1.4% | |
| Open-market buy | 23/01/19–23/01/20 | 23/01/23 | 38,139 sh2 trades | $5.00avg. | $190,695 | +5.5% | |
| Open-market buy | 23/01/12 | 23/01/17 | 5,378 sh | $4.95 | $26,621.1 | +0.8% | |
| Open-market buy | 23/01/10–23/01/11 | 23/01/12 | 309,070 sh2 trades | $4.79avg. | $1,479,178.8 | +81.2% |